Results 201 to 210 of about 45,032 (261)

Subacute Cutaneous Lupus Erythematosus Secondary to Intravenous Immunoglobulin Infusions. [PDF]

Cureus
Fleshman T, Depew I, Snider W, Cook S.
europepmc   +1 more source

Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Afimetoran, a Toll-Like Receptor 7 and 8 Inhibitor, in Patients With Cutaneous Lupus Erythematosus: A Phase 1b Randomized, Double-Blind, Placebo-Controlled Study. [PDF]

ACR Open Rheumatol
Hosein F, Ignatenko S, Chadwick KD, Zhu L, Baribaud F, Saini J, Bach T, Aras U, Zhang W, Karabeber H, Dawes M, Harrison M, Carayannopoulos LN, Krishna G.   +13 more
europepmc   +1 more source

An update on clinical trials for cutaneous lupus erythematosus. [PDF]

J Dermatol
Xie L, Lopes Almeida Gomes L, Stone CJ, Faden DF, Werth VP.   +4 more
europepmc   +1 more source

Update on cutaneous lupus erythematosus

Indian Journal of Dermatology, Venereology, and Leprology, 2012
openaire   +2 more sources

Cutaneous lupus erythematosus: Expanding clinical trial eligibility criteria based on quality of life data. [PDF]

J Am Acad Dermatol
Faden DF, Xie L, Stone CJ, Lopes Almeida Gomes L, Eldaboush A, Ricco C, Feng R, Werth VP.   +7 more
europepmc   +1 more source

Role of neutrophils in cutaneous lupus erythematosus. [PDF]

J Dermatol
Yamamoto T.
europepmc   +1 more source

Subacute cutaneous lupus erythematosus following osimertinib therapy for non-small cell lung cancer: A case report. [PDF]

JAAD Case Rep
Kim EJ, DeSimone MS, Shi CR.
europepmc   +1 more source

Expert consensus achieved on a working core outcome set for cutaneous lupus erythematosus research in survey following the 5th International Conference on Cutaneous Lupus Erythematosus (ICCLE). [PDF]

Lupus Sci Med
Zhang AJ, Perez-Chada LM, Werth VP, Merola JF.   +3 more
europepmc   +1 more source

TEN-like Acute Cutaneous Lupus Erythematosus-A Diagnostic Conundrum. [PDF]

Indian Dermatol Online J
Chalumuru S, Gopal KVT, Raju PVK, Devi BG.   +3 more
europepmc   +1 more source